Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

vertex-headquarters

Vertex’s Orkambi can be used in even younger cystic fibrosis patients, says European Commission

January 22, 2019 Manufacturing and Production, Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma

Vertex has announced that the European Commission has decided to approve a label extension in the region for Orkambi (lumacaftor/ivacaftor) …
News
mesothelioma

Pushing for progress in mesothelioma

January 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …
Feature

Just 10% of those harmed in clinical trials in India receive compensation

January 21, 2019 Sales and Marketing India, WHO, clinical trials, compensation, health

Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have …
News
lilly_building_with_american_flag_web

Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma

January 21, 2019 Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure

Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …
News
celgene_1_02

Celgene signs deals with two Massachusetts-based biotechs

January 21, 2019 Sales and Marketing Celgene, Kyn, Obsidian, cell therapy, immuno oncology, immuno-oncology

New Jersey-based biotechnology firm Celgene has signed deals with two Massachusetts-based biotechs: immuno-oncology specialist Kyn therapeutics and cell therapy firm …
News

Philip Hampton to step down from chairman role at GSK

January 21, 2019 Sales and Marketing Chairman, GSK, GlaxoSmithKline, appointment, philip hampton

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
News
imp_pologne2

NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma

January 21, 2019 Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma

Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 18, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Netherlands, Novo Nordisk, Roche, astra zeneca, prcing, sequiris, top 10, uk politics

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …
News

Abbvie’s chronic lymphocytic leukaemia drug Venclytxo scores greenlight from NICE

January 18, 2019 Medical Communications, Sales and Marketing AbbVie, NHS, NICE, Venclyxto, leukaemia, pharma

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s …
News

Eli Lilly’s Verzenios scores NICE recommendation for advanced breast cancer

January 17, 2019 Sales and Marketing Cancer, Eli Lilly, NICE, Verzenios, breast cancer, pharma

Breast cancer patients in England and Wales now have access to another treatment option, as NICE announces its recommendation of …
News
abbottweb

Abbott to boost heart valve therapy portfolio with acquisition of Cephea Valve Technologies

January 17, 2019 Manufacturing and Production, Sales and Marketing Abbott, Cephea, acquistion, mitral valve disease, pharma

As mergers and acquisitions pick up again for the New Year, Abbott has revealed plans to buy medical device firm …
News
920x920

Sacklers accused of personally directing deceptive OxyContin sales tactics

January 17, 2019 Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler

Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …
News
douglas_watson

Former CEO of Novartis’ US operations joins board of cancer immunotherapy firm

January 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that Douglas G …
Appointment
perjeta-e1339339399552

Scotland recommends Roche’s Perjeta for HER2+ metastatic breast cancer

January 15, 2019 Manufacturing and Production, Sales and Marketing Breast cancer; Roche; Scotland, NHS, Perjeta, UK, pharma

Breast cancer patients in Scotland are set to receive an additional treatment option, as the Scottish Medicines Consortium announces its …
News
sean_bohen

AstraZeneca’s chief medical officer announces resignation amid wave of departures

January 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025